Head and Neck Cancer Treatment Bronx NY

Incomplete and interrupted radiation treatment is a common problem among Medicare patients with head and neck cancer, a new study has found. Researchers analyzed data from 5,086 Medicare patients diagnosed with head and neck cancer between 1997 and 2003 and found that nearly 40 percent of them experienced interruptions in radiation therapy or failed to complete the course of therapy.

Local Companies

John J. Caronna
(212) 746-2304
520 East 70th Street
New York, NY
Eugenia Gamboa
(212) 305-5586
710 West 168th Street
New York, NY
Roger Alexander Bonomo
(212) 289-0540
1 East 87th Street
New York, NY
Adam N. Bender
(212) 876-5670
1150 Park Ave
New York, NY
Jay E. Selman, MD
212 288 6060
737 Park Avenue
New York, NY
Robert E. Barrett
(212) 288-8874
71 East 77th St
New York, NY
Norman Latov
(212) 305-2700
710 West 168th Street
New York, NY
Jay E. Selman, MD
212-288-6060
737 Park Avenue
New York, NY
Jeffrey C. Allen
(212) 870-9407
170 East End Avenue
New York, NY
Satish K Kadakia, MD
(516) 572-3107
2201 Hempstead Tpke
East Meadow, NY
Data Provided by:
  

Provided By:

MONDAY, Sept. 21 (HealthDay News) -- Incomplete and interrupted radiation treatment is a common problem among Medicare patients with head and neck cancer, a new study has found.

Researchers analyzed data from 5,086 Medicare patients diagnosed with head and neck cancer between 1997 and 2003 and found that nearly 40 percent of them experienced interruptions in radiation therapy or failed to complete the course of therapy.

People who had surgery before radiation treatment were more likely to complete the treatment without interruption than were those who did not have surgery (70 percent versus 52 percent). People with co-existing illnesses, those who had undergone chemotherapy and those whose disease had spread to surrounding lymph nodes were less likely to do so, the study found.

The findings are in the September issue of Archives of Otolaryngology -- Head & Neck Surgery.

"Surgical patients may be more likely to complete radiotherapy for several reasons," wrote Megan Dann Fesinmeyer, of the Fred Hutchinson Cancer Research Center in Seattle, and her research colleagues. "First, characteristics that make patients good candidates for surgery may also make them more likely to complete radiotherapy. Because comorbidities are known to decrease survival in patients with head and neck cancer, healthier patients may be chosen by surgeons to complete more rigorous treatments (e.g., surgery in addition to radiotherapy)."

The study authors added that people "willing to undergo major surgery to treat their disease may also be more motivated to complete a full course of uninterrupted radiation therapy, despite any toxic effects of treatment that may occur."

More research is needed to determine the factors associated with incomplete or interrupted radiation therapy among those who don't have surgery, the researchers noted.

More information

The U.S. National Cancer Institute has more about head and neck cancer.

SOURCE: JAMA/Archives journals, news release, Sept. 21, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Drug Combo Proves Powerful Against Lung Cancer Bronx NY
A two-drug combination treatment proved successful in safely slowing advanced non-small cell lung cancer in a recent clinical trial. In the study, a phase 3 trial involving 768 people with the disease, those who had erlotinib (Tarceva) added to their dose of the bevacizumab (Avastin) saw the progression of the disease slow more than if on bevacizumab alone.
- Increased Heart Disease Risks Bronx NY
- Breast Cancer Treatment Bronx NY
- Open Prostatectomy Versus Laparoscopic Procedure Bronx NY
- Hormone Therapy for Prostate Cancer Bronx NY
- Head and Neck Cancer Risk Bronx NY
- Risks for Childhood Cancer Survivors Bronx NY
- Delayed Prostate Cancer Therapy Bronx NY
- Early Breast Cancer Detection Bronx NY